Advertisement

Belgian Poison Centre impact on healthcare expenses of unintentional poisonings: a cost–benefit analysis

  • Anne-Marie K. DescampsEmail author
  • Peter De Paepe
  • Walter A. Buylaert
  • Martine A. Mostin
  • Dominique M. Vandijck
Original article
  • 10 Downloads

Abstract

Objectives

This study evaluates the impact of the Belgian Poison Centre (BPC) on national healthcare expenses for calls from the public for unintentional poisonings.

Methods

The probability of either calling the BPC, consulting a general practitioner (GP) or consulting an emergency department (ED) was examined in a telephone survey (February–March 2016). Callers were asked what they would have done in case of unavailability of the BPC. The proportion and cost for ED-ambulatory care, ED 24-h observation or hospitalisation were calculated from individual invoices. A cost–benefit analysis was performed.

Results

Unintentional cases (n = 485) from 1045 calls to the BPC were included. After having called the BPC, 92.1% did not seek further medical help, 4.2% consulted a GP and 3.7% went to an ED. In the absence of the BPC, 13.8% would not have sought any further help, 49.3% would have consulted a GP and 36.9% would have gone to the hospital. The cost–benefit ratio of the availability of the BPC as versus its absence was estimated at 5.70.

Conclusions

Financial savings can be made if people first call the BPC for unintentional poisonings.

Keywords

Poison control centre Cost–benefit ratio Unintentional poisonings Decision tree Healthcare expenses Public health 

Abbreviations

BPC

Belgian Poison Centre

ED

Emergency department

ED-amb

Emergency department ambulatory care

ED-24 h

Emergency department 24-h observation

FPS

Federal Public Service

GP

General practitioner

GUH

Ghent University Hospital

Hosp

Hospitalisation

PCC

Poison Control Centre

Notes

Compliance with ethical standards

Conflict of interest

The authors report no declarations of interests.

References

  1. Anell A, Persson M (2001) Toxicologic information center’s hotline: well-received and cost-effective for the society. Lakartidningen 98(24):2926–2930Google Scholar
  2. Belgium.be. Brussels (Belgium): Belgian Federal Government. A statistical overview of the Belgian population: http://www.belgium.be/en/about_belgium/country/Population. Accessed 02 Dec 2017
  3. Blizzard JC, Michels JE, Richardson WH et al (2008) Cost-benefit analysis of a regional poison center. Clin Toxicol (Phila) 46(5):450–456CrossRefGoogle Scholar
  4. Friedman LS, Krajewski A, Vannoy E et al (2014) The association between U.S. Poison Center assistance and length of stay and hospital charges. Clin Toxicol (Phila) 52(3):198–206CrossRefGoogle Scholar
  5. Galvão TF, Silva MT, Silva CD et al (2011) Impact of a poison control center on the length of hospital stay of poisoned patients: retrospective cohort. Sao Paulo Med J 129(1):23–29CrossRefGoogle Scholar
  6. Galvão TF, Silva EN, Silva MT et al (2012) Economic evaluation of poison centers: a systematic review. Int J Technol Assess Health Care 28(2):86–92CrossRefGoogle Scholar
  7. Giffin S, Heard SE (2009) Budget cuts and U.S. Poison Centers—regional challenges create a nationwide problem. Clin Toxicol (Phila) 47(8):790–791CrossRefGoogle Scholar
  8. Harrison MD, Dragaulis JR, Slack MK (1996) Cost-effectiveness of regional poison control centers. Arch Intern Med 156(27):2601–2608CrossRefGoogle Scholar
  9. Kearney TE, Olson KR, Bero L et al (1995) Health care cost effects of public use of a regional poison control center. West J Med 162(6):499–504Google Scholar
  10. King WD, Palmisano PA (1991) Poison control centers: can their value be measured? South Med J 84(6):722–726CrossRefGoogle Scholar
  11. LoVecchio F, Curry SC, Waszolek R et al (2008) Poison control centers decrease emergency healthcare utilization costs. J Med Toxicol 4(4):221–224CrossRefGoogle Scholar
  12. Miller TR, Lestina DC (1997) Costs of poisoning in the United States and savings from poison control centers: a benefit-cost analysis. Ann Emerg Med 29(2):239–245CrossRefGoogle Scholar
  13. Phillips KA, Homan RK, Hiatt PH et al (1998) The costs and outcomes of restricting public access to poison control centers. Results from a natural experiment. Med Care 36(3):271–280CrossRefGoogle Scholar
  14. RIZIV (2017) Brussels (Belgium): National Health and Disability Insurance. http://www.inami.fgov.be/fr/Pages/default.aspx. Accessed 12 Jan 2016
  15. Spiller HA, Singleton MD (2011) Comparison of incidence of hospital utilization for poisoning and other injury types. Public Health Rep 126(1):94–99CrossRefGoogle Scholar
  16. Stavros P (2011) Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting. BMJ 342:d1766CrossRefGoogle Scholar
  17. The Lewin Group (2012) Final report on the value of the poison center system. Prepared for: American Association of Poison Control Centers (AAPC). The Lewin Group (US)Google Scholar
  18. Thompson CA (2009) Poison control centers suffer state budget cuts. Am J Health Syst Pharm 66(19):1682–1687Google Scholar
  19. Toverud EL, Pike E, Walløe L (2009) The National Poison Center in Norway: user satisfaction and a health economic evaluation. Eur J Clin Pharmacol 65(9):935–940CrossRefGoogle Scholar
  20. Van den Heede K, Dubois C, Devriese S et al (2016) Organisation and payment of emergency care services in Belgium: current situation and options for reform. Brussels: Belgian Health Care Knowledge Centre (KCE) p 6–7, p 14Google Scholar
  21. Vassilev ZP, Marcus SM (2007) The impact of a poison control center on the length of hospital stay for patients with poisoning. J Toxicol Environ Health 70(2):107–110CrossRefGoogle Scholar
  22. Woolf AD, Karnes DK, Kirrane BM (2001) Preserving the United States’s poison control system. Clin Toxicol (Phila) 49(4):284–286CrossRefGoogle Scholar
  23. Zaloshnja E, Miller T, Jones P et al (2003) The impact of poison control centers on poisoning-related visits to EDs—United States. Am J Emerg Med 26(3):310–315CrossRefGoogle Scholar

Copyright information

© Swiss School of Public Health (SSPH+) 2019

Authors and Affiliations

  1. 1.Department of Pharmacology, Faculty of Medicine and Health SciencesGhent UniversityGhentBelgium
  2. 2.Department of Biomedical Sciences, Faculty of Medicine and Life SciencesHasselt UniversityDiepenbeekBelgium
  3. 3.Antigifcentrum/Centre AntipoisonsBrusselsBelgium
  4. 4.Department of Emergency MedicineGhent University HospitalGhentBelgium
  5. 5.Department of Public Health and Health EconomicsGhent UniversityGhentBelgium
  6. 6.Department of Patient Safety and Health Economics, Faculty of Medicine and Life SciencesHasselt UniversityDiepenbeekBelgium

Personalised recommendations